BIOX
BIOX
NASDAQ · Chemicals

Bioceres Crop Solutions Corp

$0.35
+0.02 (+5.32%)
As of Jun 30, 10:43 PM ET ·
Financial Highlights (FY 2026)
Revenue
332.62M
Net Income
-55,299,949
Gross Margin
39.0%
Profit Margin
-16.6%
Rev Growth
+0.5%
D/E Ratio
1.04
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.0% 39.0% 35.4% 35.4%
Operating Margin -0.7% -0.6% 15.8% 13.1%
Profit Margin -16.6% -15.8% 12.8% 14.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 332.62M 331.00M 10.13M 10.46M
Gross Profit 129.66M 129.02M 3.59M 3.71M
Operating Income -2,228,553 -1,995,917 1.61M 1.37M
Net Income -55,299,949 -49,527,270 1.30M 1.47M
Gross Margin 39.0% 39.0% 35.4% 35.4%
Operating Margin -0.7% -0.6% 15.8% 13.1%
Profit Margin -16.6% -15.8% 12.8% 14.0%
Rev Growth +0.5% +0.5% +24.0% +22.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 5.39M 5.39M 7.53M 9.76M
Total Equity 5.17M 5.17M 24.77M 27.77M
D/E Ratio 1.04 1.04 0.30 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 14.23M 13.45M 2.20M 2.21M
Free Cash Flow 1.19M 1.17M